| Visual Eyes At Mizner Park | |
|
333 Plaza Real, Boca Raton, FL 33432-3938 | |
| (561) 392-8383 | |
| (561) 392-1134 |
| Full Name | Visual Eyes At Mizner Park |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 333 Plaza Real, Boca Raton, Florida |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689904575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC4314 (Florida) | Primary |
| Provider Name | Mark A Horowitz |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043358823 PECOS PAC ID: 3274555388 Enrollment ID: I20060103000389 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Aaron J Evans |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1811144850 PECOS PAC ID: 0648338749 Enrollment ID: I20081017000590 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Michael Haugen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902896558 PECOS PAC ID: 4183738842 Enrollment ID: I20110531000668 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Gary E Goberville |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346233780 PECOS PAC ID: 2860655776 Enrollment ID: I20120511000370 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Giselle A Radice |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366542045 PECOS PAC ID: 3971722471 Enrollment ID: I20140916000854 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Ryan C Beck |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1649654369 PECOS PAC ID: 1850699620 Enrollment ID: I20160411002147 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Kelly Heren |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1740630466 PECOS PAC ID: 9032480017 Enrollment ID: I20170809002880 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Belkis Perez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285159178 PECOS PAC ID: 9537425509 Enrollment ID: I20171107001934 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Joanna Ashley Galasso |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1326303264 PECOS PAC ID: 5294981627 Enrollment ID: I20190205002636 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Dominic Villanti |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1508348012 PECOS PAC ID: 0143561043 Enrollment ID: I20190402001869 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Tracy Kimmelman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1447640370 PECOS PAC ID: 4082945357 Enrollment ID: I20191017001895 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Murad I Zayed |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821667312 PECOS PAC ID: 1355734211 Enrollment ID: I20220217000988 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Adriana M Garcia Aybar |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1700520608 PECOS PAC ID: 5698147411 Enrollment ID: I20230203002108 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Jacob Ethan Strous |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376276386 PECOS PAC ID: 6608248430 Enrollment ID: I20230203002607 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Steven Adrien |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669133625 PECOS PAC ID: 6204209133 Enrollment ID: I20230223002594 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Provider Name | Jacqueline Rosenberg |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1457818320 PECOS PAC ID: 9638543168 Enrollment ID: I20230323000581 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Visual Eyes At Mizner Park 333 Plaza Real, Boca Raton, FL 33432-3938 Ph: (561) 392-8383 | Visual Eyes At Mizner Park 333 Plaza Real, Boca Raton, FL 33432-3938 Ph: (561) 392-8383 |
News Archive
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Kidney patients who take calcium supplements to lower their phosphorous levels may be at a 22 per cent higher risk of death than those who take other non-calcium based treatments, according to a new study by Women's College Hospital's Dr. Sophie Jamal.
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels - making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
› Verified 2 days ago
Caruso Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 6000 Glades Rd Ste 1040, Boca Raton, FL 33431 Phone: 561-368-5065 | |
Dr. Tamara Lee Maule, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8903 Glades Rd, Bay A 1, Boca Raton, FL 33434 Phone: 561-477-3524 Fax: 561-477-3576 | |
At Your Home Eyecare, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 21214 N Sweetwater Ln, Boca Raton, FL 33428 Phone: 954-536-8905 Fax: 954-370-4546 | |
Wayne P Tepper Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 333 Plaza Real, Boca Raton, FL 33432 Phone: 561-392-8383 | |
Haeun Kim, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6100 Glades Rd Ste 107, Boca Raton, FL 33434 Phone: 561-288-3055 | |
Joann Parise, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 318 E Palmetto Park Rd, Boca Raton, FL 33432 Phone: 561-338-0081 Fax: 561-338-8291 | |
Steven D. Sheiner Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 7035 Beracasa Way, Suite 101, Boca Raton, FL 33433 Phone: 561-391-3334 Fax: 561-338-3432 |